Atlas Trials

Radiation and Immune Checkpoints Blockade in Metastatic NSCLC (BMS # CA209-632)

Clinical trial NCT03168464 · TERMINATED

Trial details

NCT number
NCT03168464
Sponsor
Weill Medical College of Cornell University
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Non Small Cell Lung Cancer Metastatic
Start date
2017-10-09
Primary completion
2022-03-11
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.